One page, the whole story.
Nectar Lifesciences Limited
NSE: NECLIFEHealthcare₹222 Cr
“Debt-shed promoter play at 0.4x book, cephalosporins reload.”
₹11.44
-1.63%₹0.19 today
Day low ₹11.30Day high ₹11.70
Market view
our read, in one sentence, with the evidence one tap awayEODconviction recomputed 21:46No clear market view today
The signals we track (volume, delivery, price trend, deals, breadth and flows) aren't aligned for NECLIFEtoday. That isn't bearish, just inconclusive.
Why now
today's active factors, delivery data and signals worth reviewingNear 52W Low
Trading near 52-week low
Strongsignal strength
Safety checks
India-specific risk checks.
Business quality
the company itself, each lens scored and explained: a separate read from the Market Setup aboveEODfundamentals to FY26 Q433
The fundamentals carry real weak spots
Four fundamentals lenses on the company itself: valuation, growth, returns & margins, and financial health, judged against the stock's sector. A separate read from the Market Setup above.
1 pass0 neutral2 fail3 of 4 scored
ValuationNo data
—
Not enough data to score this factor
GrowthDECLINING
0
Growth is soft or negative
Returns & MarginsWEAK
0
Weak returns and margins
Financial HealthSTRONG
100
Strong balance sheet
Financials
income, balance sheet, cash flow, dividends and corporate actionsEODaudited to FY26Concalls
management commentary from earnings calls, summarisedEODlatest call 31 Mar '26Filings
exchange disclosures summarised as they are filed✦ AI summary: about 30s after the exchangePeers
how the stock stacks up against its closest listed comparablesEODprices end-of-dayData as of 19 Jun 2026, 9:46 pm